Author: digi

Global Start-Up Playbook: Country, IRB/IEC and Contracting Nuances

November 15, 2025November 15, 2025 digi

Global Start-Up Playbook: Country, IRB/IEC and Contracting Nuances Global Start-Up Playbook: Country, IRB/IEC and Contracting Nuances Introduction to Global Study Start-Up in Clinical Trials The initiation of clinical trials often involves a complex landscape of regulatory requirements and operational intricacies. In this tutorial, we will delve deeply into the nuances of study start-up across different…

Study Start-Up (Reg Docs, Budgets, Contracts)

Tracking Start-Up Milestones From Feasibility to Site Ready-to-Enroll

November 15, 2025November 15, 2025 digi

Tracking Start-Up Milestones From Feasibility to Site Ready-to-Enroll Tracking Start-Up Milestones From Feasibility to Site Ready-to-Enroll Understanding the intricate processes involved in study start-up mechanisms is crucial for clinical operations professionals, especially for those engaged in polarix clinical trials. This guide outlines a step-by-step approach to tracking milestones from the feasibility assessment to the site-ready-to-enroll…

Study Start-Up (Reg Docs, Budgets, Contracts)

Site Network Partnerships vs Standalone Sites: Operational Pros and Cons

November 15, 2025November 15, 2025 digi

Site Network Partnerships vs Standalone Sites: Operational Pros and Cons Site Network Partnerships vs Standalone Sites: Operational Pros and Cons Site selection and qualification are pivotal components in the success of clinical trials. The decision to participate in a multi-site network or remain a standalone site has significant implications for clinical research management. This guide…

Site Selection & Qualification

Regulatory and Ethics Considerations in Site Qualification Strategies

November 15, 2025November 15, 2025 digi

Regulatory and Ethics Considerations in Site Qualification Strategies Regulatory and Ethics Considerations in Site Qualification Strategies The successful execution of a clinical trial hinges on the meticulous selection and qualification of trial sites. In the context of regulatory compliance and ethical standards, professionals in clinical operations, regulatory affairs, and medical affairs face a myriad of…

Site Selection & Qualification

Remote and Hybrid Site Qualification Models After the Pandemic

November 15, 2025November 15, 2025 digi

Remote and Hybrid Site Qualification Models After the Pandemic Remote and Hybrid Site Qualification Models After the Pandemic The COVID-19 pandemic has significantly altered the landscape of clinical trials, necessitating a reevaluation of site selection and qualification processes. As clinical operations, regulatory affairs, and medical affairs professionals seek to adapt to these changes, developing effective…

Site Selection & Qualification

Aligning Site Selection With Diversity, Equity and Inclusion Goals

November 15, 2025November 15, 2025 digi

Aligning Site Selection With Diversity, Equity and Inclusion Goals Aligning Site Selection With Diversity, Equity and Inclusion Goals In the evolving landscape of clinical research, the necessity for diversity, equity, and inclusion (DEI) has garnered significant attention. Site selection is a crucial aspect of clinical trials that can either promote or hinder the achievement of…

Site Selection & Qualification

Inspection-Ready Documentation of Site Selection and Qualification Rationale

November 15, 2025November 15, 2025 digi

Inspection-Ready Documentation of Site Selection and Qualification Rationale Inspection-Ready Documentation of Site Selection and Qualification Rationale In clinical research, achieving regulatory compliance is imperative for ensuring the credibility of study results and safeguarding participant welfare. One critical component that directs this process is the comprehensive documentation of site selection and qualification rationale. This step-by-step guide…

Site Selection & Qualification

Using Real-World Data and Epidemiology to Prioritize Clinical Trial Sites

November 15, 2025November 15, 2025 digi

Using Real-World Data and Epidemiology to Prioritize Clinical Trial Sites Using Real-World Data and Epidemiology to Prioritize Clinical Trial Sites In the rapidly evolving landscape of clinical research, the necessity for strategic site selection is paramount. Utilizing real-world data (RWD) and epidemiological insights becomes increasingly critical in ensuring the success of clinical trials. This comprehensive…

Site Selection & Qualification

Central vs Local Site Selection Approaches for Global Sponsors and CROs

November 15, 2025November 15, 2025 digi

Central vs Local Site Selection Approaches for Global Sponsors and CROs Central vs Local Site Selection Approaches for Global Sponsors and CROs In the evolving landscape of clinical research, global sponsors and Contract Research Organizations (CROs) face significant challenges and decisions regarding site selection. Selecting the right clinical trial sites is crucial for efficient study…

Site Selection & Qualification

Qualification Visit Checklists That Predict Recruitment and Quality

November 15, 2025November 15, 2025 digi

Qualification Visit Checklists That Predict Recruitment and Quality Qualification Visit Checklists That Predict Recruitment and Quality In the realm of clinical trials, particularly within the framework of gilead clinical trials, the recruitment of suitable participants is pivotal to successful outcomes. To ensure adherence to ICH-GCP guidelines and regulatory requirements from bodies such as the FDA,…

Site Selection & Qualification